Get the latest Science News and Discoveries

Pumitamig plus elfetabart drozuntecan shows encouraging early activity in small cell lung cancer

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of early activity

early activity

Photo of elfetabart

elfetabart

Photo of Pumitamig

Pumitamig

Related news:

Pumitamig plus elfetabart drozuntecan shows encouraging early activity in small cell lung cancer

« Local consolidative therapy does not improve survival after dual immunotherapy in metastatic NSCLC

Perioperative atezolizumab plus chemotherapy more than doubles event-free survival in resectable stage II–IIIB NSCLC »